Australian Pharmaceutical Industries Limited
(ASX:API) has reported an increase in net profit for the year ended 31 August.
Net profit came in at $43.1 million, a 37.6 per cent increase on underlying net profit in the previous corresponding period.
EBIT also increased 13.7 per cent to $74 million on last year’s EBIT figure.
The company says it continues to expand the Priceline Pharmacy network and that its growth strategy remains on track.
The company has declared a final dividend of 2.5 cents per share fully franked.
